Dual pancreatic adrenergic and dopaminergic signaling as a therapeutic target of bromocriptine-Reference-Cited by-同舟云学术

Dual pancreatic adrenergic and dopaminergic signaling as a therapeutic target of bromocriptine

Published:2022-08 Issue:8 Volume:25 Page:104771
ISSN:2589-0042
Container-title:iScience
language:en
Short-container-title:iScience

Author:

Aslanoglou Despoina,Bertera Suzanne,Friggeri Laura,Sánchez-Soto Marta,Lee Jeongkyung,Xue Xiangning,Logan Ryan W.,Lane J. Robert,Yechoor Vijay K.,McCormick Peter J.,Meiler Jens,Free R. Benjamin,Sibley David R.,Bottino Rita,Freyberg Zachary^ORCID

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference118 articles.

1. Human beta cells produce and release serotonin to inhibit glucagon secretion from alpha cells;Almaça;Cell Rep.,2016

2. Homogeneous time-resolved forster resonance energy transfer-based assay for detection of insulin secretion;Aslanoglou;J. Vis. Exp.,2018

3. Dopamine regulates pancreatic glucagon and insulin secretion via adrenergic and dopaminergic receptors;Aslanoglou;Transl. Psychiatry,2021

4. Flexible management of enzymatic digestion improves human islet isolation outcome from sub-optimal donor pancreata;Balamurugan;Am. J. Transplant.,2003

5. Molecular pathophysiology of metabolic effects of antipsychotic medications;Ballon;Trends Endocrinol. Metab.,2014

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of Novel Tools for Dissection of Central Versus Peripheral Dopamine D2-Like Receptor Signaling in Dysglycemia;Diabetes;2024-06-13

2. Development of novel tools for dissection of central versus peripheral dopamine D₂-like receptor signaling in dysglycemia;2024-02-23

3. Dopamine in the Regulation of Glucose Homeostasis, Pathogenesis of Type 2 Diabetes, and Chronic Conditions of Impaired Dopamine Activity/Metabolism: Implication for Pathophysiological and Therapeutic Purposes;Biomedicines;2023-11-07

4. Anti-Inflammatory Effects of Peripheral Dopamine;International Journal of Molecular Sciences;2023-09-07

5. Roles of Pancreatic Islet Catecholamine Neurotransmitters in Glycemic Control and in Antipsychotic Drug–Induced Dysglycemia;Diabetes;2022-12-14